LHC Group Inc. (NASDAQ:LHCG) – Stock analysts at Oppenheimer Holdings issued their Q1 2018 EPS estimates for LHC Group in a research note issued on Tuesday. Oppenheimer Holdings analyst M. Wiederhorn forecasts that the firm will earn $0.48 per share for the quarter. Oppenheimer Holdings also issued estimates for LHC Group’s Q2 2018 earnings at $0.60 EPS, Q3 2018 earnings at $0.60 EPS, Q4 2018 earnings at $0.63 EPS and FY2018 earnings at $2.30 EPS.
LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, November 2nd. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.04. The business had revenue of $230 million for the quarter, compared to the consensus estimate of $224.60 million. LHC Group had a return on equity of 9.59% and a net margin of 3.84%. LHC Group’s quarterly revenue was up 13.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.50 earnings per share.
Other analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of LHC Group from a “buy” rating to a “sell” rating in a research report on Wednesday, January 4th. Craig Hallum assumed coverage on shares of LHC Group in a research report on Friday, December 16th. They set a “buy” rating and a $50.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the stock. LHC Group currently has a consensus rating of “Buy” and a consensus price target of $48.43.
LHC Group (NASDAQ:LHCG) traded down 1.65% during mid-day trading on Thursday, hitting $45.99. The company had a trading volume of 63,914 shares. The firm has a market capitalization of $835.91 million, a PE ratio of 23.46 and a beta of 1.04. The company’s 50 day moving average price is $44.43 and its 200-day moving average price is $40.76. LHC Group has a 12-month low of $32.04 and a 12-month high of $47.24.
In other news, CEO Keith G. Myers sold 37,848 shares of the stock in a transaction dated Wednesday, November 16th. The shares were sold at an average price of $43.69, for a total transaction of $1,653,579.12. Following the transaction, the chief executive officer now owns 144,615 shares of the company’s stock, valued at approximately $6,318,229.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Joshua L. Proffitt sold 2,098 shares of the stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $41.80, for a total transaction of $87,696.40. Following the transaction, the insider now directly owns 64,717 shares in the company, valued at approximately $2,705,170.60. The disclosure for this sale can be found here. Insiders have sold a total of 335,490 shares of company stock worth $14,569,351 in the last three months. Insiders own 18.30% of the company’s stock.
A number of institutional investors have recently made changes to their positions in the stock. Nationwide Fund Advisors boosted its position in shares of LHC Group by 5.3% in the second quarter. Nationwide Fund Advisors now owns 24,509 shares of the company’s stock valued at $1,061,000 after buying an additional 1,239 shares during the last quarter. Sei Investments Co. boosted its position in shares of LHC Group by 23.8% in the third quarter. Sei Investments Co. now owns 58,650 shares of the company’s stock valued at $2,163,000 after buying an additional 11,290 shares during the last quarter. Dalton Greiner Hartman Maher & Co. boosted its position in shares of LHC Group by 17.1% in the third quarter. Dalton Greiner Hartman Maher & Co. now owns 71,375 shares of the company’s stock valued at $2,632,000 after buying an additional 10,437 shares during the last quarter. Wasatch Advisors Inc. boosted its position in shares of LHC Group by 3.4% in the third quarter. Wasatch Advisors Inc. now owns 323,654 shares of the company’s stock valued at $11,936,000 after buying an additional 10,727 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its position in shares of LHC Group by 0.7% in the third quarter. Ameriprise Financial Inc. now owns 520,513 shares of the company’s stock valued at $19,195,000 after buying an additional 3,596 shares during the last quarter. 81.58% of the stock is currently owned by institutional investors and hedge funds.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.